Replies to post #3248 on Antares Pharma, Inc. (ATRS)

[Cave In Temptor]

Seems Medac uses BD's Physioject autoinjector platform:
Ypsomed 2012-2013 (May 28, 2013)
slide 25 - "BD has launched new Physioject with Medac for methotrexate."

Physioject appears relatively recent, with an official launch in late 2011, although it has been used in Merck Serono's Rebif RebiDose for multiple sclerosis which was approved in Europe and Australia in October 2010:
BD press release

Interestingly, the first studies in RA were sponsored by BD
human factors study
Results of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis
Patient Prefer Adherence. 2014; 8: 199–209.
"Disclosure - The study was funded and sponsored by Becton Dickinson – BD Medical Pharmaceutical Systems"


(added) Regarding the comment of different devices for EU and US, Medac uses the word "autopen" in its Jan 27, 2014 press release, which is the name of autoinjectors from Owen Munford...